Takeda taps ex-Sanofi exec Plump as CMSO

Takeda Pharmaceuticals Co. Ltd. (Tokyo:4502) named Andrew Plump as a new corporate officer and Chief Medical and Scientific Officer designate.

Plump will join Takeda on Feb. 1, replacing CMSO Tadataka Yamada after a transition period. Yamada plans to retire as CMSO and relinquish his seat on Takeda's board in June 2015. ...